CD274 and neoplasm: Modulating PD-L1 expression can reduce immune monitoring in the tumor microenvironment and prevent tumor immune escape by inhibiting T cell activation, implying that PD-L1/PD-1 signaling pathway is one of the main pathways of tumor immune escape.